PANE, FABRIZIO
PANE, FABRIZIO
DIPARTIMENTO DI MEDICINA CLINICA E CHIRURGIA
DIRECT-DETECTION OF PROVIRAL GAG SEGMENT OF HUMAN-IMMUNODEFICIENCY-VIRUS IN PERIPHERAL-BLOOD LYMPHOCYTES BY COLORIMETRIC PCR ASSAY AS A CLINICAL LABORATORY TOOL APPLIED TO DIFFERENT AT-RISK POPULATIONS
1995 Pane, Fabrizio; Butto, S.; Gobbo, M. L.; Franco, M.; Butteroni, C.; Pastore, Lucio; Maiorano, G.; Foggia, M.; Cataldo, P. T.; Guarino, A.; Tamburrini, E.; Solinas, S.; Piazza, M.; Vecchio, Giancarlo; Verani, P.; Salvatore, Francesco
In vitro acquired cellular senescence and aging specific phenotype can be distinguished on the basis of specific mRNA expression.
2002 Faraonio, Raffaella; Pane, Fabrizio; Intrieri, M.; Russo, Tommaso; Cimino, F.
In vitro acquired cellular senescence and aging-specific phenotype can be distinguished on the basis of specific mRNA expression
2002 Faraonio, Raffaella; Pane, Fabrizio; Intrieri, M; Russo, T; AND CIMINO, F.
Late relapse of acute promyelocytic leukemia treated with all- trans retinoic acid and chemotherapy: report of two cases.
2004 F., Ferrara; Selleri, Carmine; G., Mele; Serio, Bianca; S., Palmieri; B., Pocali; Pane, Fabrizio; Rotoli, Bruno
JURL-MK1 (c-kit(high)/CD30-/CD40-) and JURL-MK2 (c-kit(low)/CD30+/CD40+) cell lines: 'two-sided' model for investigating leukemic megakaryocytopoiesis.
1997 DI NOTO, Rosa; Luciano, Luigia; Lo Pardo, C.; Ferrara, F.; Frigeri, F.; Mercuro, O.; Lombardi, M. L.; Pane, Fabrizio; Vacca, C.; Manzo, C.; Salvatore, Francesco; Rotoli, Bruno; DEL VECCHIO, Luigi
XM02 PLUS CHEMOTHERAPY IS SAFE AND EFFECTIVE IN STEM CELL MOBILIZATION FOR PATIENTS CANDIDATED TO AUTOLOGOUS STEM CELL TRANSPLANTATION
2013 Grimaldi, Francesco; Madonna, Emanuela; Avilia, Simona; Ricci, P.; Andretta, Claudia; Pane, Fabrizio; Risitano, ANTONIO MARIA; DE ROSA, Gennaro
Immunohistochemistry predicts nucleophosmin (NPM) mutations in acute myeloid leukemia
2006 Falini, B; Martelli, Mp; Bolli, N; Bonasso, R; Ghia, E; Pallotta, Mt; Diverio, D; Nicoletti, I; Pacini, R; Tabarrini, A; Galletti, Bv; Mannucci, R; Roti, G; Rosati, R; Specchia, G; Liso, A; Tiacci, E; Alcalay, M; Luzi, L; Volorio, S; Bernard, L; Guarini, A; Amadori, S; Mandelli, F; Pane, Fabrizio; LO COCO, F; Saglio, G; Pelicci, Pg; Martelli, Mf; Mecucci, C.
PCR-detectable transcripts in long-term remission of P190BCR/ABL –positive acute lymphoblastic leukemia
2000 Annino, L.; Ferrari, A.; Lamanda, M.; Mandelli, F.; LO COCO, F.; Pane, Fabrizio
Transition index: new original tool to identify subsets overlapping MPN phenotypes.
2011 Marano, L; Gherghi, Marco; Pugliese, N; Madonna, E; Quintarelli, Concetta; Ciancia, R; Ciancia, G; Izzo, Barbara; Muccioli Casadei, G; Martinelli, V; Pane, Fabrizio
Multicenter independent assessment of outcomes in chronic myeloid leukemia patients treated with imatinib.
2011 Gambacorti Passerini, C; Antolini, L; Mahon, Fx; Guilhot, F; Deininger, M; Fava, C; Nagler, A; Della Casa, Cm; Morra, E; Abruzzese, E; D'Emilio, A; Stagno, F; le Coutre, P; Hurtado Monroy, R; Santini, V; Martino, B; Pane, Fabrizio; Piccin, A; Giraldo, P; Assouline, S; Durosinmi, Ma; Leeksma, O; Pogliani, Em; Puttini, M; Jang, E; Reiffers, J; Valsecchi, Mg; Kim, Dw
Identification and role of the hemostasis and thrombosis expert in the National Health System
2014 Rodeghiero, F; Morfini, M; Nozzoli, C; Manotti, C; Violi, F; Castaldo, Giuseppe; Pane, Fabrizio; Biasioli, B; Velati, C.
Preferential nuclear accumulation of JAK2V617F in CD34+ but not in granulocytic, megakaryocytic, or erythroid cells of patients with Philadelphia-negative myeloproliferative neoplasia.
2010 Rinaldi, Cr; Rinaldi, P; Alagia, A; Gemei, M; Esposito, N; Formiggini, F; Martinelli, Vincenzo; Senyuk, V; Nucifora, G; Pane, Fabrizio
CDKN2A/B alterations impair prognosis in adult BCR-ABL1-positive acute lymphoblastic leukemia patients.
2011 Iacobucci, I; Ferrari, A; Lonetti, A; Papayannidis, C; Paoloni, F; Trino, S; Storlazzi, Ct; Ottaviani, E; Cattina, F; Impera, L; Abbenante, Mc; Vignetti, M; Vitale, A; Potenza, L; Paolini, S; Soverini, S; Pane, Fabrizio; Luppi, M; Fo?, R; Baccarani, M; Martinelli, G.
Selective strong synergism of Ruxolitinib and second generation tyrosine kinase inhibitors to overcome bone marrow stroma related drug resistance in chronic myelogenous leukemia.
2013 Quintarelli, Concetta; DE ANGELIS, Biagio; Errichiello, S; Caruso, S; Esposito, N; Colavita, I; Raia, M; Pagliuca, S; Pugliese, N; Risitano, ANTONIO MARIA; Picardi, Marco; Luciano, L; Saglio, G; Martinelli, G; Pane, Fabrizio
Charlson comorbidity index and adult comorbidity evaluation-27 scores might predict treatment compliance and development of pleural effusions in elderly patients with chronic myeloid leukemia treated with second-line dasatinib.
2011 Breccia, M; Latagliata, R; Stagno, F; Luciano, L; Gozzini, A; Castagnetti, F; Fava, C; Cavazzini, F; Annunziata, M; Russo Rossi, A; Pregno, P; Abruzzese, E; Vigneri, P; Rege Cambrin, G; Sica, S; Pane, Fabrizio; Santini, V; Specchia, G; Rosti, G; Alimena, G.
Analysis of Bone Marrow Microenviroment Factors As Early Markers of Response in Patients with Newly Diagnosed Bcr-Abl Positive CML in Chronic Phase Treated with Nilotinib.
2012 Quintarelli, Concetta; DE ANGELIS, Biagio; Errichiello, Santa; S., Caruso; N., Esposito; L., Luciano; S., Paratore; C., Galimberti; S., Soverini; C., Terragna; D., Cilloni; G., Saglio; G., Martinelli; F., Giles; A., Hochhaus; Pane, Fabrizio
Reduced Expression Level of SHP1 Gives An Additive Survival Advantage to the Ph plus Cells of Chronic Myeloid Leukemia (CML) Patients and Provides a Novel Pretreatment Predictor of Major Molecular Response Achievement in CML Patients
2009 Esposito, N.; Quintarelli, Concetta; Colavita, I.; Pane, Fabrizio
THIOTEPA AND MELPHALAN AS NEW CONDITIONING REGIMEN FOR AUTOLOGOUS TRANSPLANTATION IN MULTIPLE LYELOMA
2013 Grimaldi, Francesco; Madonna, Emanuela; Avilia, Simona; Pane, Fabrizio; Risitano, ANTONIO MARIA; DE ROSA, Gennaro
Alterazioni piastriniche: definizione immunologica e molecolare
1998 G., Fratellanza; Pane, Fabrizio; Covelli, Bianca; T., Quarantelli; S., Formisano
Specific messanger RNA as indicators of neoplasia.
2000 Salvatore, F.; Sacchetti, L.; Castaldo, Giuseppe; Pane, Fabrizio
| Titolo | Tipologia | Data di pubblicazione | Autore(i) | File |
|---|---|---|---|---|
| DIRECT-DETECTION OF PROVIRAL GAG SEGMENT OF HUMAN-IMMUNODEFICIENCY-VIRUS IN PERIPHERAL-BLOOD LYMPHOCYTES BY COLORIMETRIC PCR ASSAY AS A CLINICAL LABORATORY TOOL APPLIED TO DIFFERENT AT-RISK POPULATIONS | 1.1 Articolo in rivista | 1995 | Pane, Fabrizio; Butto, S.; Gobbo, M. L.; Franco, M.; Butteroni, C.; Pastore, Lucio; Maiorano, G.; Foggia, M.; Cataldo, P. T.; Guarino, A.; Tamburrini, E.; Solinas, S.; Piazza, M.; Vecchio, Giancarlo; Verani, P.; Salvatore, Francesco | |
| In vitro acquired cellular senescence and aging specific phenotype can be distinguished on the basis of specific mRNA expression. | 1.1 Articolo in rivista | 2002 | Faraonio, Raffaella; Pane, Fabrizio; Intrieri, M.; Russo, Tommaso; Cimino, F. | |
| In vitro acquired cellular senescence and aging-specific phenotype can be distinguished on the basis of specific mRNA expression | 1.1 Articolo in rivista | 2002 | Faraonio, Raffaella; Pane, Fabrizio; Intrieri, M; Russo, T; AND CIMINO, F. | |
| Late relapse of acute promyelocytic leukemia treated with all- trans retinoic acid and chemotherapy: report of two cases. | 1.1 Articolo in rivista | 2004 | F., Ferrara; Selleri, Carmine; G., Mele; Serio, Bianca; S., Palmieri; B., Pocali; Pane, Fabrizio; Rotoli, Bruno | |
| JURL-MK1 (c-kit(high)/CD30-/CD40-) and JURL-MK2 (c-kit(low)/CD30+/CD40+) cell lines: 'two-sided' model for investigating leukemic megakaryocytopoiesis. | 1.1 Articolo in rivista | 1997 | DI NOTO, Rosa; Luciano, Luigia; Lo Pardo, C.; Ferrara, F.; Frigeri, F.; Mercuro, O.; Lombardi, M. L.; Pane, Fabrizio; Vacca, C.; Manzo, C.; Salvatore, Francesco; Rotoli, Bruno; DEL VECCHIO, Luigi | |
| XM02 PLUS CHEMOTHERAPY IS SAFE AND EFFECTIVE IN STEM CELL MOBILIZATION FOR PATIENTS CANDIDATED TO AUTOLOGOUS STEM CELL TRANSPLANTATION | 4.2 Abstract in Atti di convegno | 2013 | Grimaldi, Francesco; Madonna, Emanuela; Avilia, Simona; Ricci, P.; Andretta, Claudia; Pane, Fabrizio; Risitano, ANTONIO MARIA; DE ROSA, Gennaro | |
| Immunohistochemistry predicts nucleophosmin (NPM) mutations in acute myeloid leukemia | 1.1 Articolo in rivista | 2006 | Falini, B; Martelli, Mp; Bolli, N; Bonasso, R; Ghia, E; Pallotta, Mt; Diverio, D; Nicoletti, I; Pacini, R; Tabarrini, A; Galletti, Bv; Mannucci, R; Roti, G; Rosati, R; Specchia, G; Liso, A; Tiacci, E; Alcalay, M; Luzi, L; Volorio, S; Bernard, L; Guarini, A; Amadori, S; Mandelli, F; Pane, Fabrizio; LO COCO, F; Saglio, G; Pelicci, Pg; Martelli, Mf; Mecucci, C. | |
| PCR-detectable transcripts in long-term remission of P190BCR/ABL –positive acute lymphoblastic leukemia | 1.1 Articolo in rivista | 2000 | Annino, L.; Ferrari, A.; Lamanda, M.; Mandelli, F.; LO COCO, F.; Pane, Fabrizio | |
| Transition index: new original tool to identify subsets overlapping MPN phenotypes. | 4.2 Abstract in Atti di convegno | 2011 | Marano, L; Gherghi, Marco; Pugliese, N; Madonna, E; Quintarelli, Concetta; Ciancia, R; Ciancia, G; Izzo, Barbara; Muccioli Casadei, G; Martinelli, V; Pane, Fabrizio | |
| Multicenter independent assessment of outcomes in chronic myeloid leukemia patients treated with imatinib. | 1.1 Articolo in rivista | 2011 | Gambacorti Passerini, C; Antolini, L; Mahon, Fx; Guilhot, F; Deininger, M; Fava, C; Nagler, A; Della Casa, Cm; Morra, E; Abruzzese, E; D'Emilio, A; Stagno, F; le Coutre, P; Hurtado Monroy, R; Santini, V; Martino, B; Pane, Fabrizio; Piccin, A; Giraldo, P; Assouline, S; Durosinmi, Ma; Leeksma, O; Pogliani, Em; Puttini, M; Jang, E; Reiffers, J; Valsecchi, Mg; Kim, Dw | |
| Identification and role of the hemostasis and thrombosis expert in the National Health System | 1.1 Articolo in rivista | 2014 | Rodeghiero, F; Morfini, M; Nozzoli, C; Manotti, C; Violi, F; Castaldo, Giuseppe; Pane, Fabrizio; Biasioli, B; Velati, C. | |
| Preferential nuclear accumulation of JAK2V617F in CD34+ but not in granulocytic, megakaryocytic, or erythroid cells of patients with Philadelphia-negative myeloproliferative neoplasia. | 1.1 Articolo in rivista | 2010 | Rinaldi, Cr; Rinaldi, P; Alagia, A; Gemei, M; Esposito, N; Formiggini, F; Martinelli, Vincenzo; Senyuk, V; Nucifora, G; Pane, Fabrizio | |
| CDKN2A/B alterations impair prognosis in adult BCR-ABL1-positive acute lymphoblastic leukemia patients. | 1.1 Articolo in rivista | 2011 | Iacobucci, I; Ferrari, A; Lonetti, A; Papayannidis, C; Paoloni, F; Trino, S; Storlazzi, Ct; Ottaviani, E; Cattina, F; Impera, L; Abbenante, Mc; Vignetti, M; Vitale, A; Potenza, L; Paolini, S; Soverini, S; Pane, Fabrizio; Luppi, M; Fo?, R; Baccarani, M; Martinelli, G. | |
| Selective strong synergism of Ruxolitinib and second generation tyrosine kinase inhibitors to overcome bone marrow stroma related drug resistance in chronic myelogenous leukemia. | 1.1 Articolo in rivista | 2013 | Quintarelli, Concetta; DE ANGELIS, Biagio; Errichiello, S; Caruso, S; Esposito, N; Colavita, I; Raia, M; Pagliuca, S; Pugliese, N; Risitano, ANTONIO MARIA; Picardi, Marco; Luciano, L; Saglio, G; Martinelli, G; Pane, Fabrizio | |
| Charlson comorbidity index and adult comorbidity evaluation-27 scores might predict treatment compliance and development of pleural effusions in elderly patients with chronic myeloid leukemia treated with second-line dasatinib. | 1.1 Articolo in rivista | 2011 | Breccia, M; Latagliata, R; Stagno, F; Luciano, L; Gozzini, A; Castagnetti, F; Fava, C; Cavazzini, F; Annunziata, M; Russo Rossi, A; Pregno, P; Abruzzese, E; Vigneri, P; Rege Cambrin, G; Sica, S; Pane, Fabrizio; Santini, V; Specchia, G; Rosti, G; Alimena, G. | |
| Analysis of Bone Marrow Microenviroment Factors As Early Markers of Response in Patients with Newly Diagnosed Bcr-Abl Positive CML in Chronic Phase Treated with Nilotinib. | 1.5 Abstract in rivista | 2012 | Quintarelli, Concetta; DE ANGELIS, Biagio; Errichiello, Santa; S., Caruso; N., Esposito; L., Luciano; S., Paratore; C., Galimberti; S., Soverini; C., Terragna; D., Cilloni; G., Saglio; G., Martinelli; F., Giles; A., Hochhaus; Pane, Fabrizio | |
| Reduced Expression Level of SHP1 Gives An Additive Survival Advantage to the Ph plus Cells of Chronic Myeloid Leukemia (CML) Patients and Provides a Novel Pretreatment Predictor of Major Molecular Response Achievement in CML Patients | 1.5 Abstract in rivista | 2009 | Esposito, N.; Quintarelli, Concetta; Colavita, I.; Pane, Fabrizio | |
| THIOTEPA AND MELPHALAN AS NEW CONDITIONING REGIMEN FOR AUTOLOGOUS TRANSPLANTATION IN MULTIPLE LYELOMA | 1.5 Abstract in rivista | 2013 | Grimaldi, Francesco; Madonna, Emanuela; Avilia, Simona; Pane, Fabrizio; Risitano, ANTONIO MARIA; DE ROSA, Gennaro | |
| Alterazioni piastriniche: definizione immunologica e molecolare | 1.5 Abstract in rivista | 1998 | G., Fratellanza; Pane, Fabrizio; Covelli, Bianca; T., Quarantelli; S., Formisano | |
| Specific messanger RNA as indicators of neoplasia. | 4.1 Articoli in Atti di convegno | 2000 | Salvatore, F.; Sacchetti, L.; Castaldo, Giuseppe; Pane, Fabrizio |